Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

5‐Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy, Valentin David, Mireille Verdier, et al.
Cancer Science (2020) Vol. 111, Iss. 9, pp. 3142-3154
Open Access | Times Cited: 378

Showing 26-50 of 378 citing articles:

HDAC3-Mediated Deacetylation of p21 Stabilizes Protein Levels and Promotes 5-FU Resistance in Colorectal Cancer Cells
Weilin Jin, J. Wang, Yang Feng, et al.
Advances in Cancer Biology - Metastasis (2025), pp. 100136-100136
Open Access | Times Cited: 1
Chemoresistance mechanisms to 5-Fluorouracil and reversal strategies in lung and breast cancer
Chunge Zhong, Shengnan Wang, Wenjie Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Natural Alternatives in the Treatment of Colorectal Cancer: A Mechanisms Perspective
Karen Vanessa Fernandez-Muñoz, Ángel Sánchez‐Barrera, Marco Antonio Meraz‐Ríos, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 326-326
Open Access | Times Cited: 1
A novel view on an old drug, 5-fluorouracil: an unexpected RNA modifier with intriguing impact on cancer cell fate
Mounira Chalabi‐Dchar, Tanguy Fenouil, Christelle Machon, et al.
NAR Cancer (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 54
Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil
Jung Ho Han, Min-Jeong Kim, Hyeon Jin Kim, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5406-5406
Open Access | Times Cited: 42
Local co-delivery of 5-fluorouracil and curcumin using Schiff's base cross-linked injectable hydrogels for colorectal cancer combination therapy
Hamid Sadeghi Abandansari, Sarvenaz Pakian, Mohammad Reza Nabid, et al.
European Polymer Journal (2021) Vol. 157, pp. 110646-110646
Closed Access | Times Cited: 42
A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway
Fei Lin, Guanglin Zhang, Xihan Yang, et al.
Journal of Ethnopharmacology (2022) Vol. 303, pp. 115933-115933
Closed Access | Times Cited: 36
Glutathione Peroxidase 4 as a Therapeutic Target for Anti-Colorectal Cancer Drug-Tolerant Persister Cells
Xiaoli Zhang, Yiming Ma, Jianhui Ma, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 35
Computational Identification of Druggable Bioactive Compounds from Catharanthus roseus and Avicennia marina against Colorectal Cancer by Targeting Thymidylate Synthase
Md Rashedul Islam, Md Abdul Awal, Ahmed Khames, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2089-2089
Open Access | Times Cited: 29
Molecular mechanisms of resveratrol as chemo and radiosensitizer in cancer
Sandra Cotino‐Nájera, Luis A. Herrera, Guadalupe Domínguez-Gómez, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Total neoadjuvant therapy in rectal cancer: the evidence and expectations
Ludmila Boublíková, Alena Nováková, Jaromír Šimša, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 192, pp. 104196-104196
Open Access | Times Cited: 18
Colorectal cancer and therapy response: a focus on the main mechanisms involved
Sara Tirendi, Barbara Marengo, Cinzia Domenicotti, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 17
One‐Pot Synthesis of Luminescent and Photothermal Carbon Boron‐Nitride Quantum Dots Exhibiting Cell Damage Protective Effects
Grazia M. L. Consoli, Ludovica Maugeri, Nicolò Musso, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 7
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
Lysine-Specific Demethylase 1 Inhibitors: A Comprehensive Review Utilizing Computer-Aided Drug Design Technologies
Di Han, Jiarui Lu, Baoyi Fan, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 550-550
Open Access | Times Cited: 6
Synergistic eradicating impact of 5-fluouracil with FeO nanoparticles-diethyldithiocarbamate in colon cancer spheroids
Marwa M. Abu‐Serie
Nanomedicine (2024) Vol. 19, Iss. 11, pp. 979-994
Closed Access | Times Cited: 6
Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer
Yanan Zheng, Siyue Lou, Jun Lu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 7
Open Access | Times Cited: 6
Innovative Strategies to Combat 5-Fluorouracil Resistance in Colorectal Cancer: The Role of Phytochemicals and Extracellular Vesicles
Muttiah Barathan, Ahmad Khusairy Zulpa, Sook Luan Ng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7470-7470
Open Access | Times Cited: 6
Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature
Khalil Hodroj, David Barthélémy, Jean‐Christophe Lega, et al.
ESMO Open (2021) Vol. 6, Iss. 3, pp. 100125-100125
Open Access | Times Cited: 36
Long noncoding RNA HAGLR sponges miR‐338‐3p to promote 5‐Fu resistance in gastric cancer through targeting the LDHA‐glycolysis pathway
Jing Hu, Lujie Huang, Qi Ding, et al.
Cell Biology International (2021) Vol. 46, Iss. 2, pp. 173-184
Open Access | Times Cited: 36
A Colorectal Cancer 3D Bioprinting Workflow as a Platform for Disease Modeling and Chemotherapeutic Screening
Yordan Sbirkov, Diana Molander, Clément Milet, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 33
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
Ying Liu, Xiang Ao, Guoqiang Ji, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 33
A synopsis of modern - day colorectal cancer: Where we stand
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188699-188699
Closed Access | Times Cited: 25
Role of autophagy in drug resistance and regulation of osteosarcoma (Review)
Yanchuan Pu, Jin Wang, Shizhong Wang
Molecular and Clinical Oncology (2022) Vol. 16, Iss. 3
Open Access | Times Cited: 23
Low-dose orlistat promotes the therapeutic effect of oxaliplatin in colorectal cancer
Qing Zhang, Yue Zhou, Xingyu Feng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113426-113426
Closed Access | Times Cited: 23

Scroll to top